Shifts & Narratives #8 – Post-summer check-up on the regime shift

September 16, 2021

Investors have enjoyed stellar performances over the last twelve months. A 60/40 traditional global equity/bond portfolio returned around 19% on a one-year horizon, well above even the rosiest expectations of the recovery from the Covid-19-induced slump. The S&P 500 is up +100% from last year’s bottom – an iconic figure that says a lot about the buoyant market sentiment.

At this time of year when we go back to school, market uncertainty is rising not only because of recent news about the Covid-19 Delta variant, but, more importantly, because new elements are emerging in the battle of the narratives underpinning financial markets. One narrative becomes dominant until a new one challenges and then eventually replaces it, triggering a regime shift. As narratives are connected with expectations, they play a critical role in shaping valuations, their equilibrium, and their excesses.

So far this year, we have seen the continuation of the never-ending monetary umbrella narrative, coupled with the great recovery lifting risk assets. The euphoria around this exceptional rebound in growth has led to the idea

of a more structural economic and earnings boom propelled by the technological advances that accelerated during the Covid-19 crisis (somewhat mirroring the experience of the ‘Roaring Twenties’). No doubt, the battle of narratives will see a winner forming a fresh new consensus, through a sort of discovery process, around the key question: what will be left of the consensual rebound in activity and inflation?

Subscribe to the Amundi Research Newsletter

Important legal information.

Please read these terms and conditions carefully.
This part of our website is for the attention of Professional and Institutional Investors and Home Office Personnel only. In the European Union, it is not for non-professional investors as defined by MIFID or in each local regulation for the general public. This website is solely for informational purposes.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service. Any securities, products, or services referenced may not be registered for sale with the relevant authority in your jurisdiction and may not be regulated or supervised by any governmental or similar authority in your jurisdiction.
Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction. There is no guarantee that any targeted performance or forecast will be achieved.
Amundi owns the copyright and all other intellectual property rights in the website.

By choosing “Accept” you represent that you understand and agree to all the legal terms and conditions of this website.

Praesent venenatis quis, sed at dolor justo